UAB “Altechna R&D”, brand name WORKSHOP OF PHOTONICS, is one of the fastest-growing companies in the Lithuanian laser technology and photonics sector. It cooperates with international companies and research centers in developing and introducing new products to the market.
One of the major company’s activities is laser products and solutions development, to process transparent, semiconductor, and dialectical structures with ultra-short pulse high-frequency laser.
One of the cornerstones in the fight against the COVID-19 pandemic is the reliable diagnosis of both SARS-CoV-2 and other viruses. The massive use of rapid tests indicates that the subject has one or another antibody. The test results enable quick measures to be taken like target self-isolation or allow a return to communication. Besides, there is a need for methods to quickly and efficiently determine which coronavirus is present in the test organism, how the virus interacts with drugs, i.e., how the body responds to treatment.
The research and experimental development activities developed during the project will be related to COVID-19, which includes R&D on therapeutic and medical devices (accurate viral diagnostics / viral medical diagnostics) and will focus on the development of an inexpensive microfluidic cuvette to minimize the use of test substance, would transport and mix the used liquids as quickly as possible and would be suitable for various recording methods – colorimetric, luminescent, electrochemical, etc.
A prototype of a cuvette will be tested in a laboratory. If a test is successful, a small series of cuvettes, sufficient to validate its suitability for use, will be produced. Once the suitability is confirmed, a production line for cuvettes will be developed by reproducing a prototype of the production equipment developed during the project.
The initiated project develops a multilayer plastic cuvette for microfluidic testing of samples in point-of-care devices. It will be suitable for a variety of recording methods – electrochemical, luminescent, colorimetric, etc.
Funded under the 2014-2020 Measure “COVID-19 R&D” of Priority 1 “Promotion of Research, Experimental Development and Innovation” of the European Union Funds Investment Operational Program.
Funded by the European Regional Development Fund.
Funded as part of the European Union’s response to the COVID-19 pandemic.
The name of the project – “Investments in R&D required for the creation of microfluidic cells”.
Project executor – UAB “Altechna R&D”.
The total value of the project – EUR 974,437.02.
Funding from the European Regional Development Fund – EUR 779,549.62.
The project is implemented from 2021 January 1 until 2022 February 10.
The laser system will enable to write the data on ceramic tablets stored for a…
The project aims to develop international partnerships by seeking opportunities to participate in EU R&D…
WOP has received funding at the last call of the Eurostars 2 international program to…